Patent details
EP3914620 Title: TREATMENT OF T CELL LYMPHOMA
Basic Information
- Publication number:
- EP3914620
- PCT Application Number:
- EP2020051234
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP207015595
- PCT Publication Number:
- WO2020152081
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF T CELL LYMPHOMA
- French Title of Invention:
- TRAITEMENT DU LYMPHOME À CELLULES T
- German Title of Invention:
- BEHANDLUNG VON T-ZELL-LYMPHOMEN
- SPC Number:
Dates
- Filing date:
- 20/01/2020
- Grant date:
- 26/11/2025
- EP Publication Date:
- 01/12/2021
- PCT Publication Date:
- 30/07/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/11/2025
- EP B1 Publication Date:
- 26/11/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 20/01/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/11/2025
- Name:
- Innate Pharma
- Address:
- 117, Avenue de Luminy, 13009 Marseille, France (FR)
Inventor
1
- Name:
- PATUREL, Carine
- Address:
- France (FR)
2
- Name:
- ABDELAZIM, Hatem
- Address:
- France (FR)
Priority
- Priority Number:
- 201962795194 P
- Priority Date:
- 22/01/2019
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07K 16/28; A61K 31/282; A61K 31/7068; A61K 39/395; A61P 35/00; A61P 35/02; G01N 33/53;
Publication
European Patent Bulletin
- Issue number:
- 202548
- Publication date:
- 26/11/2025
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 31/07/2026
- Annual Fee Number:
- 7
- Annual Fee Amount:
- 82 Euro
- Penalty Fee Amount:
- 20 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|